The completion marks the conclusion to an M&A saga that has been ongoing since 2022, with a transaction valued at $179.3 million or $5.295 per share....
Aspect Biosystems is 3D Biotek's biggest rival. Aspect Biosystems was founded in 2013, and is headquartered in Vancouver, British Columbia. Like 3D Biotek, Aspect Biosystems also works within the Biotechnology sector. Aspect Biosystems generates $1.6M more revenue vs. 3D Biotek.